Henrik Stage

Henrik Stage is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Executive Chair and Co-founder of Fuse Vectors since January 2023, Henrik also holds advisory and board roles at Notify Therapeutics and Biomia Aps, as well as being a board member for ResoTher Pharma. As the founder and CEO of Adcendo since January 2017, Henrik leads efforts to develop novel antibody-drug-conjugates for cancer treatment. Previously, Henrik served as CFO for RhoVac ApS and Synact Pharma ApS, and CEO and CFO at Santaris Pharma A/S, where significant funding and partnership agreements were secured. Educationally, Henrik holds a Master’s degree in Finance from Copenhagen Business School and attended Rysensteen Gymnasium.